Takeuchi Ikuya, Ishida Hideyuki, Ohsawa Tomonori, Yokoyama Masaru, Hoshino Takanobu, Hashimoto Daijo, Osada Hisato, Mastumoto Yoshiro, Miura Tsuyoshi
Dept. of Surgery, Saitama Medical Center Saitama Medical School.
Gan To Kagaku Ryoho. 2004 Oct;31(11):1800-2.
We histologically examined the effect of hepatic arterial infusion of degradable starch microspheres mixed with adriamycin and mitomycin C (DSM therapy) for liver metastases of colorectal cancer. The subjects were 15 liver metastatic lesions from 9 patients with colorectal cancer who underwent potentially curative hepatectomy after DSM therapy. Ages were ranged from 36 to 71 years old (mean, 57). The ratio of male to female was 4 to 5. Six patients had synchronous lesion(s). A single injection dosage of the DSM therapy was comprised of 300-600 mg degradable starch microspheres, 30 mg ADM, and 10 mg MMC. Three lesions from the two patients who were given a single DSM therapy did not show any radiographical changes. In addition, histological examination of these lesions demonstrated a grade 1 effect. The radiographical effect of the 12 lesions from the 7 patients, who were given the DSM therapy at least three times, showed SD in 4 lesions, PR in 6 lesions, and PD in two lesions. Histological examination of these lesions demonstrated Grade 2 in 4 lesions and Grade 3 in 5 lesions. In conclusion, it was histologically confirmed that a repeated DSM therapy could cause satisfactory effects beyond expectations by radiographic imaging in patients with liver metastases of colorectal cancer.
我们通过组织学方法研究了肝动脉灌注可降解淀粉微球联合阿霉素及丝裂霉素C(DSM疗法)对结直肠癌肝转移的疗效。研究对象为9例结直肠癌患者的15个肝转移病灶,这些患者在接受DSM疗法后接受了根治性肝切除术。年龄范围为36至71岁(平均57岁)。男女比例为4比5。6例患者有同步病灶。DSM疗法的单次注射剂量包括300 - 600毫克可降解淀粉微球、30毫克阿霉素和10毫克丝裂霉素C。接受单次DSM疗法的2例患者的3个病灶未显示任何影像学变化。此外,对这些病灶的组织学检查显示为1级疗效。7例接受至少3次DSM疗法的患者的12个病灶的影像学疗效显示,4个病灶为疾病稳定(SD),6个病灶为部分缓解(PR),2个病灶为疾病进展(PD)。对这些病灶的组织学检查显示,4个病灶为2级,5个病灶为3级。总之,组织学证实,重复DSM疗法对结直肠癌肝转移患者可产生超出影像学预期的满意疗效。